RecruitingPhase 2NCT05235919

Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder

Repetitive Transcranial Magnetic Stimulation to Promote Helpful Self-regulatory Behaviour in Children and Youth With Autism Spectrum Disorder

Sponsor

Holland Bloorview Kids Rehabilitation Hospital

Enrollment

50 participants

Start Date

Sep 22, 2022

Study Type

INTERVENTIONAL

Conditions

Autism Spectrum Disorder Self-Regulation, Emotion

Summary

This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.

Eligibility

Min Age: 9 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Sham stimulation and a medical device called repetitive transcranial magnetic stimulation (rTMS) for people with autism spectrum disorder and self-regulation, emotion. The study is currently recruiting participants at 1 location. People eligible for this study include aged 9 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.